Silmitasertib Terminated Phase 2 Trials for Infections, Coronavirus / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04668209Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)